A compound preparation of cephalosporin antibiotics and its preparation method and use
Combination of cephalosporin antibiotics with pomegranate peel extract, 3-epital betasteine acid, leaf flower extract and Atractylodes extract were prepared, which solved the adverse reactions of cephalosporin antibiotics and improved the drug's Safety and widespread use, and enhances antibacterial and hemostatic effects.
Patent Information
- Application Number
- CN202410219583.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-28
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-02-28
AI Technical Summary
Cephalosporin antibiotics have adverse reactions such as diarrhea, nausea, vomiting and liver damage, which affect the safety and widespread use.
Combined cephalosporin antibiotics with pomegranate peel extract, 3-epital betasteic acid, leaf flower extract and Atractylodes extract, extract the active ingredients by enzymatic lysis and macroporous resin adsorption, and prepare a compound preparation for antibacterial, anti-inflammatory and hemostatic .
It reduces the adverse reactions of cephalosporin antibiotics, improves the safety and widespread use of drugs, ensures normal liver function, and enhances hemostatic and anti-inflammatory effects.
Smart Images

Figure BDA0004717688610000081 
Figure BDA0004717688610000111 
Figure BDA0004717688610000151
Abstract
Description
Technical Field
[0001] This invention belongs to the field of pharmaceutical technology, specifically relating to a compound preparation of cephalosporin antibiotics, its preparation method, and its uses. Background Technology
[0002] Cephalosporin antibiotics are a widely used class of bactericidal and anti-inflammatory drugs. The development of cephalosporin antibiotics has gone through five generations: First-generation cephalosporins (such as cefadroxil, cefazolin, cephalexin, and cefadroxil) are mainly used for killing Gram-positive bacteria, but they have certain nephrotoxic side effects; Second-generation cephalosporins (such as cefuroxime, cefamandole, cefotiam, cefaclor, and cefprozil) are also used for killing Gram-positive bacteria. While effective against Gram-negative bacteria, their nephrotoxicity is reduced. Third-generation cephalosporins (such as ceftazidime, cefixime, cefotaxime, cefoperazone sodium, and ceftriaxone) are mainly used for the killing of Gram-negative bacteria and have almost no nephrotoxicity. Fourth-generation cephalosporins (such as cefepime and cefpirome) and fifth-generation cephalosporins (such as cefepime, cefuroxime, and ceftoro) have good bactericidal effects against both Gram-negative and Gram-positive bacteria and are not nephrotoxic.
[0003] Cephalosporin antibiotics are effective in treating respiratory infections, lung infections, urinary tract infections, sepsis, meningitis, endocarditis, and skin and soft tissue infections. They can also be used as prophylactic medications for surgical procedures.
[0004] However, cephalosporin antibiotics still have some adverse reactions, including diarrhea, nausea, vomiting, and elevated transaminase levels, which affect their safety and widespread use. Therefore, it is necessary to develop safer and more reliable drug compositions to reduce side effects and expand their applicability. Summary of the Invention
[0005] Existing cephalosporin antibiotics have various adverse reactions, including diarrhea, nausea, vomiting, and elevated transaminase levels, affecting their safety and widespread use. This invention provides a compound preparation of cephalosporin antibiotics, its preparation method, and its uses. The cephalosporin antibiotic is combined with various drug extracts, including pomegranate peel extract, 3-epibetrazine, *Eriocaulon buergerianum* extract, and *Atractylodes lancea* extract. This combination exhibits good anti-inflammatory, anti-edema, analgesic, anti-diarrheal, anti-constipation, anti-vomiting, rash-relieving, and anti-fever effects. It can reduce various adverse reactions of cephalosporin antibiotics, ensure normal liver function, prevent elevated transaminase levels, and improve the safety of the compound drug. The specific technical solution is as follows:
[0006] A compound preparation of cephalosporin antibiotics, the compound preparation being made from the following raw materials in the indicated mass fractions: 1 part to 3 parts cephalosporin antibiotics, 0.3 parts to 1 part pomegranate peel extract, 0.1 parts to 0.3 parts 3-epibetella oleracea, 0.2 parts to 0.8 parts leaf elephant flower extract, 0.1 parts to 0.5 parts Atractylodes lancea extract, and 1 part to 2.5 parts glucose;
[0007] In the above technical solution, the cephalosporin antibiotic is cefepime, cefpirome, cefepime, cefuroxime, or ceftoro.
[0008] In the above technical solution, the preparation method of the pomegranate peel extract is as follows:
[0009] Take pomegranate peel, crush it, add deionized water, mix well, then add hemicellulase, bromelain and subtilisin, and sonicate for 1 to 1.5 hours. Then heat up to inactivate the enzymes. After cooling to room temperature, filter with a sieve, take the filtrate and adsorb it with macroporous resin, then elute with ethanol aqueous solution to obtain the eluent. Concentrate under negative pressure and freeze dry to obtain pomegranate peel extract.
[0010] The macroporous adsorption resin is AB-8 macroporous adsorption resin, HPD-100C macroporous adsorption resin, or Mitsubishi ion exchange resin SEPABEADS SP825L.
[0011] The amount of deionized water added is 4 to 6 times the weight of the pomegranate peel; the amount of hemicellulase added is 2% to 5% of the weight of the pomegranate peel, with an enzyme activity of 15,000 U / g to 25,000 U / g; the amount of bromelain added is 1% to 3% of the weight of the pomegranate peel, with an enzyme activity of 15,000 U / g to 25,000 U / g; and the amount of Bacillus subtilis protease added is 1% to 2% of the weight of the pomegranate peel, with an enzyme activity of 15,000 U / g to 25,000 U / g.
[0012] The ultrasonic enzymatic hydrolysis temperature is 38℃~45℃, and the ultrasonic frequency of the ultrasonic enzymatic hydrolysis is 15kHz~20kHz; the temperature for inactivating the enzyme by heating is above 90℃; the time for inactivating the enzyme by heating is 15min~20min; the mesh size of the sieve is 200 mesh~250 mesh; and the ethanol volume concentration of the ethanol aqueous solution is 30%~40%.
[0013] In the above technical solution, the preparation method of the leaf elephant flower extract is as follows:
[0014] Take the leaf elephant flower, crush it, add water and boil for 50 min to 80 min to obtain the decoction. After cooling to room temperature, add anhydrous ethanol, mix with ultrasound, filter with a 3 kDa ultrafiltration membrane, collect the filtrate with less than 3 kDa, concentrate under negative pressure, freeze dry to obtain the leaf elephant flower extract.
[0015] The amount of anhydrous ethanol added is 0.5 to 1 times the volume of the decoction; the ultrasonic mixing time is 30 to 50 minutes.
[0016] In the above technical solution, the preparation method of the Atractylodes lancea extract is as follows:
[0017] Take the rhizome of Atractylodes lancea, crush it, add deionized water, then add hemicellulase and Lactobacillus plantarum, ferment at 30℃~35℃ for 18h~20h, then heat up to sterilize and inactivate the enzyme, cool to room temperature, filter with a mesh screen, take the filtrate and adsorb it with macroporous resin, then elute with ethanol aqueous solution to obtain the eluent, concentrate under negative pressure, freeze dry to obtain Atractylodes lancea extract.
[0018] The macroporous adsorption resin is AB-8 macroporous adsorption resin, HPD-100C macroporous adsorption resin, or Mitsubishi ion exchange resin SEPABEADS SP825L.
[0019] The amount of deionized water added is 6 to 8 times the weight of Atractylodes lancea rhizome; the amount of hemicellulase added is 1.5% to 3% of the weight of Atractylodes lancea rhizome, with an enzyme activity of 15000 U / g to 25000 U / g; and the amount of Lactobacillus plantarum added is 3% to 5% of the weight of Atractylodes lancea rhizome.
[0020] The sieve mesh size is 200-250 mesh; the temperature for sterilization and enzyme inactivation is above 90°C, and the sterilization and enzyme inactivation time is 15-20 minutes; the ethanol volume concentration of the ethanol aqueous solution is 30%-40%.
[0021] The preparation method of the above-mentioned compound preparation of cephalosporin antibiotics includes the following steps:
[0022] S1: Prepare the following ingredients by mass fraction: 80-100 parts purified water, 1-3 parts cephalosporin antibiotics, 0.3-1 part pomegranate peel extract, 0.1-0.3 parts 3-epiotabetracia acid, 0.2-0.8 parts leaf elephant flower extract, 0.1-0.5 parts Atractylodes lancea extract, and 1-2.5 parts glucose.
[0023] S2: Heat purified water to 35℃~40℃, add glucose, pomegranate peel extract, 3-epiotabetulinic acid, leaf elephant flower extract and Atractylodes lancea extract and mix well, then add cephalosporin antibiotics, mix well, and finally spray dry to obtain the compound preparation.
[0024] The above-mentioned compound preparation of a cephalosporin antibiotic is used to prepare an injection, oral medication, spray, or topical application with pharmaceutically acceptable excipients for antibacterial, anti-inflammatory, and hemostatic purposes.
[0025] The present invention discloses a compound preparation of cephalosporin antibiotics, its preparation method, and its uses. Compared with the prior art, the advantages are as follows:
[0026] I. This invention uses cephalosporin antibiotics combined with pomegranate peel extract, 3-epiotabetulinic acid, *Eriocaulon buergerianum* extract, and *Atractylodes lancea* extract to prepare antibacterial, anti-inflammatory, and hemostatic agents. While enabling cephalosporin antibiotics to exert their antibacterial and anti-inflammatory effects, this invention significantly reduces the adverse side effects of cephalosporin antibiotics, resulting in better safety and wider applicability. Furthermore, the combined use of cephalosporin antibiotics with pomegranate peel extract, 3-epiotabetulinic acid, *Eriocaulon buergerianum* extract, and *Atractylodes lancea* extract can achieve good hemostatic effects.
[0027] II. Design of this invention pomegranate peel Enzymatic hydrolysis was performed using hemicellulase, bromelain, and subtilisin, followed by adsorption and extraction of the active substances using macroporous resin. The active ingredients eluted with ethanol-water solution have therapeutic effects on diarrhea and hemostasis. When used in combination with cephalosporin antibiotics, they can reduce the adverse reactions of diarrhea.
[0028] 3-Epidermosinic acid has anti-inflammatory, analgesic, antitumor, and anti-ulcer activities, as well as hemostatic effects; when used in combination with cephalosporin antibiotics, 3-epidermosinic acid can reduce adverse reactions such as vomiting and constipation.
[0029] IV. This invention designs an ethanol and water solvent to extract small molecule active substances from *Eriocaulon buergerianum*. The *Eriocaulon buergerianum* extract has warming and hemostatic effects, treats traumatic swelling and pain, and promotes urination and bowel movements. When used in combination with cephalosporin antibiotics, the *Eriocaulon buergerianum* extract can reduce adverse drug reactions such as diarrhea, constipation, rash, and vomiting.
[0030] V. This invention designs the Atractylodes lancea rhizome to undergo enzymatic hydrolysis and fermentation with hemicellulase and Lactobacillus plantarum, and uses macroporous resin adsorption to extract active ingredients. The Atractylodes lancea rhizome extract has the effects of drying dampness and strengthening the spleen, dispelling wind and cold, and improving eyesight. It can resist gastritis and gastric ulcers, and regulate gastrointestinal motility. In particular, it can resist liver damage. When Atractylodes lancea rhizome extract is used in combination with cephalosporin antibiotics, it can resist symptoms such as diarrhea, constipation, vomiting, rash, and fever, ensure normal liver function, reduce liver damage caused by cephalosporin antibiotics, and ensure that transaminase levels do not rise.
[0031] VI. The present invention involves heating purified water to 35℃~40℃, adding glucose, pomegranate peel extract, 3-epiotabetulinic acid, leaf elephant flower extract, and Atractylodes lancea extract, mixing them evenly, then adding cephalosporin antibiotics, mixing evenly, and finally spray drying to obtain a compound preparation. By utilizing the adhesiveness of glucose and various extract components to spray-dry and polymerize with cephalosporin antibiotics, the binding of each component is good and the binding is more uniform, ensuring the interaction effect between the components.
[0032] In summary, the combined use of pomegranate peel extract, 3-epibetrazine, leaf elephant flower extract, and Atractylodes lancea extract has good anti-inflammatory, anti-swelling, analgesic, anti-diarrheal, anti-constipation, anti-vomiting, rash-relieving, and anti-fever effects. It can reduce various adverse reactions of cephalosporin antibiotics, ensure normal liver function, prevent elevated transaminase levels, and improve the safety of compound drugs. Detailed Implementation
[0033] The present invention will be further described below with reference to specific implementation examples, but the present invention is not limited to these embodiments.
[0034] Example 1
[0035] A compound preparation of cephalosporin antibiotics, the compound preparation being made from the following raw materials in the indicated mass fractions: 2 parts cephalosporin antibiotics, 0.6 parts pomegranate peel extract, 0.2 parts 3-epibetrazine, 0.5 parts leaf elephant flower extract, 0.3 parts Atractylodes lancea extract and 2 parts glucose.
[0036] In this embodiment, the cephalosporin antibiotic is cefepime.
[0037] In this embodiment, the preparation method of pomegranate peel extract is as follows:
[0038] Take pomegranate peel, crush it, add 5 times the weight of deionized water, mix well, then add hemicellulase, bromelain and subtilisin, and sonicate at 18 kHz for 1.5 h at 42℃. Then raise the temperature to 95℃ to inactivate the enzymes for 20 min. After cooling to room temperature, filter it through a 250 mesh sieve, and adsorb the filtrate with AB-8 macroporous adsorption resin. Then elute with 35% ethanol aqueous solution to obtain the eluent. Concentrate under negative pressure and freeze dry to obtain pomegranate peel extract.
[0039] The amount of hemicellulase added was 3% of the pomegranate peel mass, with an enzyme activity of 20,000 U / g; the amount of bromelain added was 2% of the pomegranate peel mass, with an enzyme activity of 20,000 U / g; and the amount of Bacillus subtilis protease added was 1.5% of the pomegranate peel mass, with an enzyme activity of 20,000 U / g.
[0040] In this embodiment, the preparation method of the leaf elephant flower extract is as follows:
[0041] Take the leaf elephant flower, crush it, add water and boil for 60 minutes to obtain the decoction. After cooling to room temperature, add 0.8 times the volume of anhydrous ethanol to the decoction, mix ultrasonically for 40 minutes, filter with a 3kDa ultrafiltration membrane, collect the filtrate with less than 3kDa, concentrate under negative pressure, freeze dry to obtain the leaf elephant flower extract.
[0042] In this embodiment, the preparation method of the Atractylodes lancea extract is as follows:
[0043] Take Atractylodes rhizome, crush it, add 7 times the weight of deionized water, then add hemicellulase and Lactobacillus plantarum. Ferment at 33℃ for 20h, then heat to 95℃ for sterilization and enzyme inactivation for 20min. After cooling to room temperature, filter with a 250-mesh sieve, take the filtrate and adsorb it with AB-8 macroporous adsorption resin, then elute with ethanol aqueous solution with a volume concentration of 35% to obtain the eluent. Concentrate under negative pressure and freeze dry to obtain Atractylodes extract.
[0044] The amount of hemicellulase added was 2% of the weight of Atractylodes lancea rhizome, with an enzyme activity of 20,000 U / g; the amount of Lactobacillus plantarum added was 4% of the weight of Atractylodes lancea rhizome.
[0045] This embodiment describes a method for preparing a compound preparation of cephalosporin antibiotics, comprising the following steps:
[0046] S1: Prepare the following ingredients by mass fraction: 90 parts purified water, 2 parts cephalosporin antibiotics, 0.6 parts pomegranate peel extract, 0.2 parts 3-epibetella oleracea extract, 0.5 parts leaf elephant flower extract, 0.3 parts Atractylodes lancea extract and 3 parts glucose.
[0047] S2: Heat purified water to 38°C, add glucose, pomegranate peel extract, 3-epiotabetulinic acid, leaf elephant flower extract and Atractylodes lancea extract and mix well, then add cephalosporin antibiotics, mix well, and finally spray dry to obtain the compound preparation.
[0048] This embodiment describes the use of a compound preparation of a cephalosporin antibiotic. The compound preparation, together with pharmaceutically acceptable excipients, is prepared into an injection, oral medication, spray, or topical application for antibacterial, anti-inflammatory, and hemostatic purposes.
[0049] Experiment 1:
[0050] The compound preparation of this embodiment is prepared into an injection: the injection is 0.5g of compound preparation / 30mL of water for injection.
[0051] An acute injection toxicity test was conducted on mice (100 healthy mice) using the injectable formulation of this embodiment. 0.2 ml / kg of the injectable formulation was injected, and the reaction was observed. No adverse reactions were observed in any of the mice tested with the injectable formulation of this embodiment. 0.1 ml / kg of the injectable formulation was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any of the organs, and no harmful effects were observed.
[0052] Preparation of blank example injection: The injection is 0.5g compound preparation / 30mL water for injection; wherein, the compound preparation does not contain cephalosporin antibiotics.
[0053] An acute injection toxicity test was conducted on mice (100 healthy mice) using the blank sample injection. 0.2 ml / kg of the injection was injected, and the reaction was observed. No adverse reactions were observed in any mice using the blank sample injection. 0.1 ml / kg was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any organs, and no harmful effects were observed.
[0054] Experiment 2:
[0055] The compound preparation of Example 1 was prepared into a topical dressing (wound dressing): the topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of the compound preparation and 15g of sodium pyrrolidone carboxylate.
[0056] Preparation of Comparative Example 1.1: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0057] Preparation of Comparative Example 1.2: The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, 3-epibrurin acid was replaced by chitosan. Other parameters and methods were the same as in this example.
[0058] Preparation of Comparative Example 1.3: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, the leaf weevil flower extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0059] Preparation of Comparative Example 1.4 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, Atractylodes lancea extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0060] Preparation of Comparative Example 1.5 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract, 3-epiotaberenic acid, *Eriocaulon buergerianum* extract, and *Atractylodes lancea* extract were all replaced with chitosan. Other parameters and methods were the same as in this example.
[0061] Preparation of Comparative Example 1.6: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, cephalosporin antibiotics were replaced with glucose. Other parameters and methods were the same as in this example.
[0062] Hemostasis tests were performed on the topical application of Example 1 and the topical applications of Comparative Examples 1.1-1.6:
[0063] One hundred and forty healthy rabbits were selected for the experiment. Blood samples were collected before the experiment to measure transaminase levels. The rabbits were divided into seven groups (n=20 per group), with each group receiving a different topical application. The venous area of the rabbits' legs was shaved, and a shallow 1cm incision was made to create a wound model (wounds of equal distance and depth). 0.2g of the topical application was then applied, and the hemostasis time was recorded. Blood samples were collected 6 hours later to measure transaminase levels. Adverse reactions were observed within 36 hours. The experimental results are shown in Table 1 below.
[0064] Table 1 Results of hemostasis test
[0065]
[0066] The percentage change in transaminase levels is calculated as follows: (Transaminase levels measured in blood samples taken 6 hours prior to the test - Transaminase levels measured in blood samples taken before the test) / Transaminase levels measured in blood samples taken before the test.
[0067] The above results show that cephalosporin antibiotics have good anti-inflammatory effects, but can cause various adverse reactions. The addition of pomegranate peel extract, 3-epibetella oleracea extract, *Ixodes scabra* extract, and *Atractylodes lancea* extract reduces the adverse reactions of cephalosporin antibiotics and provides good hemostatic effects. The compound preparation in this embodiment has higher safety.
[0068] Example 2
[0069] A compound preparation of cephalosporin antibiotics, the compound preparation being made from the following raw materials in the indicated mass fractions: 1 part cephalosporin antibiotic, 0.3 parts pomegranate peel extract, 0.1 parts 3-epiotabetraciacid, 0.2 parts euphorbia pekinensis extract, 0.1 parts Atractylodes lancea extract and 1 part glucose.
[0070] In this embodiment, the cephalosporin antibiotic is cefpirome.
[0071] In this embodiment, the preparation method of pomegranate peel extract is as follows:
[0072] Take pomegranate peel, crush it, add 4 times the weight of deionized water, mix well, then add hemicellulase, bromelain and subtilisin, and sonicate at 15 kHz for 1 hour at 38℃. Then raise the temperature to 90℃ for 15 minutes to inactivate the enzymes. After cooling to room temperature, filter it through a 200-mesh sieve. Adsorb the filtrate with HPD-100C macroporous adsorption resin, then elute with 30% ethanol aqueous solution. The eluent is concentrated under negative pressure and freeze-dried to obtain pomegranate peel extract.
[0073] The amount of hemicellulase added was 2% of the pomegranate peel mass, with an enzyme activity of 15000 U / g; the amount of bromelain added was 1% of the pomegranate peel mass, with an enzyme activity of 15000 U / g; and the amount of Bacillus subtilis protease added was 1% of the pomegranate peel mass, with an enzyme activity of 15000 U / g.
[0074] In this embodiment, the preparation method of the leaf elephant flower extract is as follows:
[0075] Take the leaf elephant flower, crush it, add water and boil for 50 minutes to obtain the decoction. After cooling to room temperature, add 0.5 times the volume of anhydrous ethanol to the decoction, mix ultrasonically for 30 minutes, filter with a 3kDa ultrafiltration membrane, collect the filtrate with less than 3kDa, concentrate under negative pressure, freeze dry to obtain the leaf elephant flower extract.
[0076] In this embodiment, the preparation method of the Atractylodes lancea extract is as follows:
[0077] Take Atractylodes lancea rhizome, crush it, add 6 times the weight of deionized water, then add hemicellulase and Lactobacillus plantarum, ferment at 30℃ for 18 hours, then heat to 90℃ for sterilization and enzyme inactivation for 15 minutes, cool to room temperature, filter with a 200-mesh sieve, take the filtrate and adsorb it with HPD-100C macroporous adsorption resin, then elute with ethanol aqueous solution with a volume concentration of 30%, obtain the eluent, concentrate under negative pressure, freeze dry, and obtain Atractylodes lancea extract;
[0078] The amount of hemicellulase added was 1.5% of the weight of Atractylodes lancea rhizome, with an enzyme activity of 15000 U / g; the amount of Lactobacillus plantarum added was 3% of the weight of Atractylodes lancea rhizome.
[0079] The preparation method of a compound preparation of cephalosporin antibiotics according to this embodiment includes the following steps:
[0080] S1: Prepare the following ingredients by mass fraction: 80 parts purified water, 1 part cephalosporin antibiotic, 0.3 parts pomegranate peel extract, 0.1 parts 3-epiotabetracia acid, 0.2 parts leaf elephant flower extract, 0.1 parts Atractylodes lancea extract and 1 part glucose.
[0081] S2: Heat purified water to 35°C, add glucose, pomegranate peel extract, 3-epiotabetulinic acid, leaf elephant flower extract and Atractylodes lancea extract and mix well, then add cephalosporin antibiotics, mix well, and finally spray dry to obtain the compound preparation.
[0082] This embodiment describes the use of a compound preparation of a cephalosporin antibiotic, wherein the compound preparation, together with pharmaceutically acceptable excipients, is prepared into an injection, oral medication, spray, or topical application for antibacterial, anti-inflammatory, and hemostatic purposes.
[0083] Experiment 1:
[0084] The compound preparation of this embodiment is prepared into an injection: the injection is 0.5g of compound preparation / 30mL of water for injection.
[0085] An acute injection toxicity test was conducted on mice (100 healthy mice) using the injectable formulation of this embodiment. 0.2 ml / kg of the injectable formulation was injected, and the reaction was observed. No adverse reactions were observed in any of the mice tested with the injectable formulation of this embodiment. 0.1 ml / kg of the injectable formulation was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any of the organs, and no harmful effects were observed.
[0086] Preparation of blank example injection: The injection is 0.5g compound preparation / 30mL water for injection; wherein, the compound preparation does not contain cephalosporin antibiotics.
[0087] An acute injection toxicity test was conducted on mice (100 healthy mice) using the blank sample injection. 0.2 ml / kg of the injection was injected, and the reaction was observed. No adverse reactions were observed in any mice using the blank sample injection. 0.1 ml / kg was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any organs, and no harmful effects were observed.
[0088] Experiment 2:
[0089] The compound preparation of Example 2 was prepared into a topical dressing (wound dressing): the topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of the compound preparation and 15g of sodium pyrrolidone carboxylate.
[0090] Preparation of Comparative Example 2.1: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0091] Preparation of Comparative Example 2.2: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, 3-epibrurin acid was replaced by chitosan. Other parameters and methods were the same as in this example.
[0092] Preparation of Comparative Example 2.3: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, the leaf weevil flower extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0093] Preparation of Comparative Example 2.4: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, Atractylodes lancea extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0094] Preparation of Comparative Example 2.5 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract, 3-epiotaberenic acid, *Eriocaulon buergerianum* extract, and *Atractylodes lancea* extract were all replaced with chitosan. Other parameters and methods were the same as in this example.
[0095] Preparation of Comparative Example 2.6: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, cephalosporin antibiotics were replaced with glucose. Other parameters and methods were the same as in this example.
[0096] Hemostasis tests were performed on the topical application of Example 2 and the topical applications of Comparative Examples 2.1-2.6:
[0097] One hundred and forty healthy rabbits were selected for the experiment. Blood samples were collected before the experiment to measure transaminase levels. The rabbits were divided into seven groups (n=20 per group), with each group receiving a different topical application. The leg vein area of the rabbits was shaved, and a shallow 1cm incision was made to create a wound model (wounds of equal distance and depth). 0.2g of the topical application was then applied, and the hemostasis time was recorded. Blood samples were collected 6 hours later to measure transaminase levels. Adverse reactions were observed within 36 hours. The experimental results are shown in Table 2 below.
[0098] Table 2 Results of hemostasis test
[0099]
[0100] The percentage change in transaminase levels is calculated as follows: (Transaminase levels measured in blood samples taken 6 hours prior to the test - Transaminase levels measured in blood samples taken before the test) / Transaminase levels measured in blood samples taken before the test.
[0101] The above results show that cephalosporin antibiotics have good anti-inflammatory effects, but can cause various adverse reactions. The addition of pomegranate peel extract, 3-epibetella oleracea extract, *Ixodes scabra* extract, and *Atractylodes lancea* extract reduces the adverse reactions of cephalosporin antibiotics and provides good hemostatic effects. The compound preparation in this embodiment has higher safety.
[0102] Example 3
[0103] A compound preparation of cephalosporin antibiotics, the compound preparation being made from the following raw materials in the indicated mass fractions: 3 parts cephalosporin antibiotics, 1 part pomegranate peel extract, 0.3 parts 3-epibetrazine, 0.8 parts leaf elephant flower extract, 0.5 parts Atractylodes lancea extract and 2.5 parts glucose.
[0104] In this embodiment, the cephalosporin antibiotic is cefepime.
[0105] In this embodiment, the preparation method of pomegranate peel extract is as follows:
[0106] Take pomegranate peel, crush it, add 6 times the weight of deionized water, mix well, then add hemicellulase, bromelain and subtilisin, and sonicate at 20 kHz for 1.5 h at 45℃. Then raise the temperature to 100℃ to inactivate the enzymes for 20 min. After cooling to room temperature, filter it through a 250 mesh sieve. Adsorb the filtrate onto Mitsubishi SEPABEADS SP825L ion exchange resin, then elute with 40% ethanol aqueous solution. The eluent is concentrated under negative pressure and freeze-dried to obtain pomegranate peel extract.
[0107] The amount of hemicellulase added was 5% of the pomegranate peel mass, with an enzyme activity of 25000 U / g; the amount of bromelain added was 3% of the pomegranate peel mass, with an enzyme activity of 25000 U / g; and the amount of subtilisin added was 2% of the pomegranate peel mass, with an enzyme activity of 25000 U / g.
[0108] In this embodiment, the preparation method of the leaf elephant flower extract is as follows:
[0109] Take the leaf elephant flower, crush it, add water and boil for 80 minutes to obtain the decoction. After cooling to room temperature, add anhydrous ethanol equal to the volume of the decoction, sonicate and mix for 50 minutes. Filter using a 3kDa ultrafiltration membrane, collect the filtrate with less than 3kDa, concentrate under negative pressure, and freeze dry to obtain the leaf elephant flower extract.
[0110] In this embodiment, the preparation method of the Atractylodes lancea extract is as follows:
[0111] Take Atractylodes lancea rhizome, crush it, add 8 times the weight of deionized water, then add hemicellulase and Lactobacillus plantarum, ferment at 35℃ for 20h, then heat to 100℃ for sterilization and enzyme inactivation for 20min, cool to room temperature, filter with a 250 mesh sieve, take the filtrate and adsorb it with Mitsubishi SEPABEADS SP825L ion exchange resin, then elute with 40% ethanol aqueous solution, obtain the eluent, concentrate under negative pressure, freeze dry to obtain Atractylodes lancea extract;
[0112] The amount of hemicellulase added was 3% of the weight of Atractylodes lancea rhizome, with an enzyme activity of 25,000 U / g; the amount of Lactobacillus plantarum added was 5% of the weight of Atractylodes lancea rhizome.
[0113] The preparation method of a compound preparation of cephalosporin antibiotics according to this embodiment includes the following steps:
[0114] S1: Prepare the following ingredients by mass fraction: 100 parts purified water, 3 parts cephalosporin antibiotics, 1 part pomegranate peel extract, 0.3 parts 3-epiotabetraciacid, 0.8 parts leaf elephant flower extract, 0.5 parts Atractylodes lancea extract and 5 parts glucose.
[0115] S2: Heat purified water to 40℃, add glucose, pomegranate peel extract, 3-epiotabetulinic acid, leaf elephant flower extract and Atractylodes lancea extract and mix well, then add cephalosporin antibiotics, mix well, and finally spray dry to obtain the compound preparation.
[0116] This embodiment describes the use of a compound preparation of a cephalosporin antibiotic, wherein the compound preparation, together with pharmaceutically acceptable excipients, is prepared into an injection, oral medication, spray, or topical application for antibacterial, anti-inflammatory, and hemostatic purposes.
[0117] Experiment 1:
[0118] The compound preparation of this embodiment is prepared into an injection: the injection is 0.5g of compound preparation / 30mL of water for injection.
[0119] An acute injection toxicity test was conducted on mice (100 healthy mice) using the injectable formulation of this embodiment. 0.2 ml / kg of the injectable formulation was injected, and the reaction was observed. No adverse reactions were observed in any of the mice tested with the injectable formulation of this embodiment. 0.1 ml / kg of the injectable formulation was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any of the organs, and no harmful effects were observed.
[0120] Preparation of blank example injection: The injection is 0.5g compound preparation / 30mL water for injection; wherein, the compound preparation does not contain cephalosporin antibiotics.
[0121] An acute injection toxicity test was conducted on mice (100 healthy mice) using the blank sample injection. 0.2 ml / kg of the injection was injected, and the reaction was observed. No adverse reactions were observed in any mice using the blank sample injection. 0.1 ml / kg was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any organs, and no harmful effects were observed.
[0122] Experiment 2:
[0123] The compound preparation of Example 3 was prepared into a topical dressing (wound dressing): the topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of the compound preparation and 15g of sodium pyrrolidone carboxylate.
[0124] Preparation of Comparative Example 3.1: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0125] Preparation of Comparative Example 3.2: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, 3-epiotabetulinic acid was replaced by chitosan. Other parameters and methods were the same as in this example.
[0126] Preparation of Comparative Example 3.3: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, the leaf weevil flower extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0127] Preparation of Comparative Example 3.4: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, Atractylodes lancea extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0128] Preparation of Comparative Example 3.5 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract, 3-epiotaberenic acid, *Eriocaulon buergerianum* extract, and *Atractylodes lancea* extract were all replaced with chitosan. Other parameters and methods were the same as in this example.
[0129] Preparation of Comparative Example 3.6 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, cephalosporin antibiotics were replaced with glucose. Other parameters and methods were the same as in this example.
[0130] Hemostasis tests were performed on the topical application of Example 3 and the topical applications of Comparative Examples 3.1-3.6:
[0131] One hundred and forty healthy rabbits were selected. Blood samples were collected before the experiment to measure transaminase levels. The rabbits were divided into seven groups (n=20 per group), with each group receiving a different topical application. The leg vein area of the rabbits was shaved, and a shallow 1cm incision was made to create a wound model (wounds of equal distance and depth). 0.2g of the topical application was then applied, and the hemostasis time was recorded. Blood samples were collected 6 hours later to measure transaminase levels. Adverse reactions were observed within 36 hours. The experimental results are shown in Table 3 below.
[0132] Table 3 Results of hemostasis test
[0133]
[0134] The percentage change in transaminase levels is calculated as follows: (Transaminase levels measured in blood samples taken 6 hours prior to the test - Transaminase levels measured in blood samples taken before the test) / Transaminase levels measured in blood samples taken before the test.
[0135] The above results show that cephalosporin antibiotics have good anti-inflammatory effects, but can cause various adverse reactions. The addition of pomegranate peel extract, 3-epibetella oleracea extract, *Ixodes scabra* extract, and *Atractylodes lancea* extract reduces the adverse reactions of cephalosporin antibiotics and provides good hemostatic effects. The compound preparation in this embodiment has higher safety.
[0136] Example 4
[0137] A compound preparation of cephalosporin antibiotics, the compound preparation being made from the following raw materials in the indicated mass fractions: 1.5 parts cephalosporin antibiotics, 0.4 parts pomegranate peel extract, 0.15 parts 3-epibetrazine, 0.3 parts leaf elephant flower extract, 0.2 parts Atractylodes lancea extract and 1.5 parts glucose.
[0138] In this embodiment, the cephalosporin antibiotic is cefuroxime protonate.
[0139] In this embodiment, the preparation method of pomegranate peel extract is as follows:
[0140] Take pomegranate peel, crush it, add 4.5 times the weight of deionized water, mix well, then add hemicellulase, bromelain and subtilisin, and sonicate at 16 kHz for 1 hour at 39℃. Then raise the temperature to 91℃ for 16 minutes to inactivate the enzymes. After cooling to room temperature, filter it through a 200-mesh sieve, and adsorb the filtrate with AB-8 macroporous adsorption resin. Then elute with 32% ethanol aqueous solution to obtain the eluent. Concentrate under negative pressure and freeze dry to obtain pomegranate peel extract.
[0141] The amount of hemicellulase added was 2.5% of the pomegranate peel mass, with an enzyme activity of 16000 U / g; the amount of bromelain added was 1.5% of the pomegranate peel mass, with an enzyme activity of 16000 U / g; and the amount of Bacillus subtilis protease added was 1.2% of the pomegranate peel mass, with an enzyme activity of 18000 U / g.
[0142] In this embodiment, the preparation method of the leaf elephant flower extract is as follows:
[0143] Take the leaf elephant flower, crush it, add water and boil for 55 minutes to obtain the decoction. After cooling to room temperature, add 0.6 times the volume of anhydrous ethanol to the decoction, mix ultrasonically for 35 minutes, filter with a 3kDa ultrafiltration membrane, collect the filtrate with less than 3kDa, concentrate under negative pressure, freeze dry to obtain the leaf elephant flower extract.
[0144] In this embodiment, the preparation method of the Atractylodes lancea extract is as follows:
[0145] Take Atractylodes lancea rhizome, crush it, add 6.5 times the weight of deionized water, then add hemicellulase and Lactobacillus plantarum. Ferment at 31℃ for 18.5h, then heat to 91℃ for sterilization and enzyme inactivation for 16min. After cooling to room temperature, filter through a 200-mesh sieve. Adsorb the filtrate with HPD-100C macroporous adsorption resin, then elute with 32% ethanol aqueous solution. The eluent is concentrated under negative pressure and freeze-dried to obtain Atractylodes lancea extract.
[0146] The amount of hemicellulase added was 1.8% of the weight of Atractylodes lancea rhizome, with an enzyme activity of 18000 U / g; the amount of Lactobacillus plantarum added was 3.5% of the weight of Atractylodes lancea rhizome.
[0147] The preparation method of the above-mentioned compound preparation of cephalosporin antibiotics includes the following steps:
[0148] S1: By mass fraction, prepare 85 parts purified water, 1.5 parts cephalosporin antibiotics, 0.4 parts pomegranate peel extract, 0.15 parts 3-epiotabetraciacid, 0.3 parts leaf elephant flower extract, 0.2 parts Atractylodes lancea extract and 2 parts glucose.
[0149] S2: Heat purified water to 36°C, add glucose, pomegranate peel extract, 3-epiotabetulinic acid, leaf elephant flower extract and Atractylodes lancea extract and mix well, then add cephalosporin antibiotics, mix well, and finally spray dry to obtain the compound preparation.
[0150] The above-mentioned compound preparation of a cephalosporin antibiotic is used to prepare an injection, oral medication, spray, or topical application with pharmaceutically acceptable excipients for antibacterial, anti-inflammatory, and hemostatic purposes.
[0151] Experiment 1:
[0152] The compound preparation of this embodiment is prepared into an injection: the injection is 0.5g of compound preparation / 30mL of water for injection.
[0153] An acute injection toxicity test was conducted on mice (100 healthy mice) using the injectable formulation of this embodiment. 0.2 ml / kg of the injectable formulation was injected, and the reaction was observed. No adverse reactions were observed in any of the mice tested with the injectable formulation of this embodiment. 0.1 ml / kg of the injectable formulation was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any of the organs, and no harmful effects were observed.
[0154] Preparation of blank example injection: The injection is 0.5g compound preparation / 30mL water for injection; wherein, the compound preparation does not contain cephalosporin antibiotics.
[0155] An acute injection toxicity test was conducted on mice (100 healthy mice) using the blank sample injection. 0.2 ml / kg of the injection was injected, and the reaction was observed. No adverse reactions were observed in any mice using the blank sample injection. 0.1 ml / kg was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any organs, and no harmful effects were observed.
[0156] Experiment 2:
[0157] The compound preparation of Example 4 was prepared into a topical dressing (wound dressing): the topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of the compound preparation and 15g of sodium pyrrolidone carboxylate.
[0158] Preparation of Comparative Example 4.1: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0159] Preparation of Comparative Example 4.2: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, 3-epigleurone acid was replaced by chitosan. Other parameters and methods were the same as in this example.
[0160] Preparation of Comparative Example 4.3: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, the leaf weevil flower extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0161] Preparation of Comparative Example 4.4: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, Atractylodes lancea extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0162] Preparation of Comparative Example 4.5 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract, 3-epiotaberenic acid, *Eriocaulon buergerianum* extract, and *Atractylodes lancea* extract were all replaced with chitosan. Other parameters and methods were the same as in this example.
[0163] Preparation of Comparative Example 4.6: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, cephalosporin antibiotics were replaced with glucose. Other parameters and methods were the same as in this example.
[0164] Hemostasis tests were performed on the topical application of Example 4 and the topical applications of Comparative Examples 4.1-4.6:
[0165] One hundred and forty healthy rabbits were selected for the experiment. Blood samples were collected before the experiment to measure transaminase levels. The rabbits were divided into seven groups (n=20 per group), with each group receiving a different topical application. The venous area of the rabbits' legs was shaved, and a shallow 1cm incision was made to create a wound model (wounds of equal distance and depth). 0.2g of the topical application was then applied, and the hemostasis time was recorded. Blood samples were collected 6 hours later to measure transaminase levels. Adverse reactions were observed within 36 hours. The experimental results are shown in Table 4 below.
[0166] Table 4 Results of hemostasis test
[0167]
[0168] The percentage change in transaminase levels is calculated as follows: (Transaminase levels measured in blood samples taken 6 hours prior to the test - Transaminase levels measured in blood samples taken before the test) / Transaminase levels measured in blood samples taken before the test.
[0169] The above results show that cephalosporin antibiotics have good anti-inflammatory effects, but can cause various adverse reactions. The addition of pomegranate peel extract, 3-epibetella oleracea extract, *Ixodes scabra* extract, and *Atractylodes lancea* extract reduces the adverse reactions of cephalosporin antibiotics and provides good hemostatic effects. The compound preparation in this embodiment has higher safety.
[0170] Example 5
[0171] A compound preparation of cephalosporin antibiotics, the compound preparation being made from the following raw materials in the indicated mass fractions: 2.5 parts cephalosporin antibiotics, 0.8 parts pomegranate peel extract, 0.25 parts 3-epiotabetraciacid, 0.7 parts euphorbia pekinensis extract, 0.4 parts Atractylodes lancea extract and 1.5 parts glucose.
[0172] In this embodiment, the cephalosporin antibiotic is ceftoro.
[0173] In this embodiment, the preparation method of pomegranate peel extract is as follows:
[0174] Take pomegranate peel, crush it, add 5.5 times the weight of deionized water, mix well, then add hemicellulase, bromelain and subtilisin, and sonicate at 18 kHz for 1.5 h at 43℃. Then raise the temperature to 98℃ for 18 min to inactivate the enzymes. After cooling to room temperature, filter it through a 250 mesh sieve. Adsorb the filtrate with HPD-100C macroporous adsorption resin, then elute with 38% ethanol aqueous solution. The eluent is concentrated under negative pressure and freeze-dried to obtain pomegranate peel extract.
[0175] The amount of hemicellulase added was 4% of the pomegranate peel mass, with an enzyme activity of 22000 U / g; the amount of bromelain added was 2.5% of the pomegranate peel mass, with an enzyme activity of 22000 U / g; and the amount of Bacillus subtilis protease added was 1.8% of the pomegranate peel mass, with an enzyme activity of 20000 U / g.
[0176] In this embodiment, the preparation method of the leaf elephant flower extract is as follows:
[0177] Take the leaf elephant flower, crush it, add water and boil for 70 minutes to obtain the decoction. After cooling to room temperature, add 0.8 times the volume of anhydrous ethanol to the decoction, mix ultrasonically for 45 minutes, filter with a 3kDa ultrafiltration membrane, collect the filtrate with less than 3kDa, concentrate under negative pressure, freeze dry to obtain the leaf elephant flower extract.
[0178] In this embodiment, the preparation method of the Atractylodes lancea extract is as follows:
[0179] Take the rhizome of Atractylodes lancea, crush it, add 7.5 times the weight of deionized water, then add hemicellulase and Lactobacillus plantarum. Ferment at 34℃ for 19 hours, then heat to 98℃ for sterilization and enzyme inactivation for 18 minutes. After cooling to room temperature, filter through a 250-mesh sieve. Adsorb the filtrate with Mitsubishi SEPABEADS SP825L ion exchange resin, then elute with ethanol aqueous solution with a volume concentration of 38%. The eluent is concentrated under negative pressure and freeze-dried to obtain the Atractylodes lancea extract.
[0180] The amount of hemicellulase added was 2.5% of the weight of Atractylodes lancea rhizome, with an enzyme activity of 22000 U / g; the amount of Lactobacillus plantarum added was 4.5% of the weight of Atractylodes lancea rhizome.
[0181] The preparation method of the above-mentioned compound preparation of cephalosporin antibiotics includes the following steps:
[0182] S1: By mass fraction, prepare 95 parts purified water, 2.5 parts cephalosporin antibiotics, 0.8 parts pomegranate peel extract, 0.25 parts 3-epiotabetraciacid, 0.7 parts leaf elephant flower extract, 0.4 parts Atractylodes lancea extract and 4 parts glucose.
[0183] S2: Heat purified water to 38°C, add glucose, pomegranate peel extract, 3-epiotabetulinic acid, leaf elephant flower extract and Atractylodes lancea extract and mix well, then add cephalosporin antibiotics, mix well, and finally spray dry to obtain the compound preparation.
[0184] The above-mentioned compound preparation of a cephalosporin antibiotic is used to prepare an injection, oral medication, spray, or topical application with pharmaceutically acceptable excipients for antibacterial, anti-inflammatory, and hemostatic purposes.
[0185] Experiment 1:
[0186] The compound preparation of this embodiment is prepared into an injection: the injection is 0.5g of compound preparation / 30mL of water for injection.
[0187] An acute injection toxicity test was conducted on mice (100 healthy mice) using the injectable formulation of this embodiment. 0.2 ml / kg of the injectable formulation was injected, and the reaction was observed. No adverse reactions were observed in any of the mice tested with the injectable formulation of this embodiment. 0.1 ml / kg of the injectable formulation was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any of the organs, and no harmful effects were observed.
[0188] Preparation of blank example injection: The injection is 0.5g compound preparation / 30mL water for injection; wherein, the compound preparation does not contain cephalosporin antibiotics.
[0189] An acute injection toxicity test was conducted on mice (100 healthy mice) using the blank sample injection. 0.2 ml / kg of the injection was injected, and the reaction was observed. No adverse reactions were observed in any mice using the blank sample injection. 0.1 ml / kg was injected into rats (100 healthy rats) daily for 15 consecutive days. No abnormal changes were observed in any organs, and no harmful effects were observed.
[0190] Experiment 2:
[0191] The compound preparation of Example 5 was prepared into a topical dressing (wound dressing): the topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of the compound preparation and 15g of sodium pyrrolidone carboxylate.
[0192] Preparation of Comparative Example 5.1: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0193] Preparation of Comparative Example 5.2 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, 3-epibrurin acid was replaced by chitosan. Other parameters and methods were the same as in this example.
[0194] Preparation of Comparative Example 5.3: Topical dressing (wound dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, the leaf weevil flower extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0195] Preparation of Comparative Example 5.4 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, Atractylodes lancea extract was replaced with chitosan. Other parameters and methods were the same as in this example.
[0196] Preparation of Comparative Example 5.5 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, pomegranate peel extract, 3-epiotabetraciacid, *Eriocaulon buergerianum* extract, and *Atractylodes lancea* extract were all replaced with chitosan. Other parameters and methods were the same as in this example.
[0197] Preparation of Comparative Example 5.6 Topical Dressing (Wound Dressing): The topical dressing contained 80g of polylactic acid / polyethylene glycol copolymer in an equal mass ratio, 2g of chitosan, 20g of a compound preparation, and 15g of sodium pyrrolidone carboxylate. In the compound preparation, cephalosporin antibiotics were replaced with glucose. Other parameters and methods were the same as in this example.
[0198] Hemostasis tests were performed on the topical application of Example 5 and the topical applications of Comparative Examples 5.1-5.6:
[0199] One hundred and forty healthy rabbits were selected. Blood samples were collected before the experiment to measure transaminase levels. The rabbits were divided into seven groups (n=20 per group), with each group receiving a different topical application. The leg vein area of the rabbits was shaved, and a shallow 1cm incision was made to create a wound model (wounds of equal distance and depth). 0.2g of the topical application was then applied, and the hemostasis time was recorded. Blood samples were collected 6 hours later to measure transaminase levels. Adverse reactions were observed within 36 hours. The experimental results are shown in Table 5 below.
[0200] Table 5 Results of hemostasis test
[0201]
[0202] The percentage change in transaminase levels is calculated as follows: (Transaminase levels measured in blood samples taken 6 hours prior to the test - Transaminase levels measured in blood samples taken before the test) / Transaminase levels measured in blood samples taken before the test.
[0203] The above results show that cephalosporin antibiotics have good anti-inflammatory effects, but can cause various adverse reactions. The addition of pomegranate peel extract, 3-epibetella oleracea extract, *Ixodes scabra* extract, and *Atractylodes lancea* extract reduces the adverse reactions of cephalosporin antibiotics and provides good hemostatic effects. The compound preparation in this embodiment has higher safety.
Claims
1. A compound preparation of cephalosporin antibiotics, characterized in that: The compound preparation is prepared from the following raw materials in mass fractions: 1 to 3 parts of cephalosporin antibiotics, 0.3 to 1 part of pomegranate peel extract, 0.1 to 0.3 parts of 3-epi-betulinic acid, 0.2 to 0.8 parts of iris extract, 0.1 to 0.5 parts of atractylodes extract and 1 to 2.5 parts of glucose; The cephalosporin antibiotic is cefepime, cefpirome, ceftobiprole, cefuroxime fosamil or ceftriaxone; The preparation method of the pomegranate peel extract comprises the following steps: taking pomegranate peel, crushing it, adding deionized water of 4 to 6 times the weight of the pomegranate peel, mixing evenly, then adding hemicellulase of 2% to 5% by weight of the pomegranate peel, bromelain of 1% to 3% by weight of the pomegranate peel, and subtilisin of 1% to 2% by weight of the pomegranate peel, performing ultrasonic enzymolysis for 1 hour to 1.5 hours, and then heating up to inactivate the enzymes; after cooling to room temperature, filtering with a mesh, taking the filtrate and adsorbing it with a macroporous resin, and then eluting it with an ethanol aqueous solution to obtain an eluate, performing negative pressure concentration, and freeze-drying to obtain the pomegranate peel extract; The preparation method of the iris flower extract comprises the following steps: taking the iris flower, crushing it, adding water and boiling it for 50 to 80 minutes to obtain a decoction, cooling it to room temperature, adding anhydrous ethanol in an amount of 0.5 to 1 times the volume of the decoction, ultrasonically mixing it, filtering it with a 3 kDa ultrafiltration membrane, collecting a filtrate with a volume less than 3 kDa, concentrating it under negative pressure, and freeze-drying it to obtain the iris flower extract; The preparation method of the Atractylodes lancea extract comprises the following steps: taking Atractylodes lancea rhizomes, crushing them, adding deionized water of 6 to 8 times the mass of the Atractylodes lancea rhizomes, adding hemicellulase of 1.5 to 3% by mass of the Atractylodes lancea rhizomes and Lactobacillus plantarum of 3 to 5% by mass of the Atractylodes lancea rhizomes, fermenting at 30 to 35° C. for 18 to 20 hours, heating to sterilize and inactivate the enzyme, cooling to room temperature, filtering with a sieve, taking the filtrate to adsorb with a macroporous resin, eluting with an ethanol aqueous solution to obtain an eluate, performing negative pressure concentration, and freeze-drying to obtain the Atractylodes lancea extract; The macroporous adsorption resin is AB-8 macroporous adsorption resin, HPD-100C macroporous adsorption resin or Mitsubishi ion exchange resin SEPABEADS SP825L.
2. The compound preparation of cephalosporin antibiotics according to claim 1, characterized in that: In the preparation method of pomegranate peel extract, the enzyme activity of hemicellulase is 15000U / g-25000U / g; the enzyme activity of bromelain is 15000U / g-25000U / g; and the enzyme activity of subtilisin is 15000U / g-25000U / g.
3. The compound preparation of cephalosporin antibiotics according to claim 1, characterized in that: In the preparation method of pomegranate peel extract, the temperature of ultrasonic enzymatic hydrolysis is 38°C to 45°C, the ultrasonic frequency of the ultrasonic enzymatic hydrolysis is 15kHZ to 20kHZ; the temperature of heating enzyme inactivation is above 90°C; the time of heating enzyme inactivation is 15min to 20min; the mesh number of the sieve is 200 mesh to 250 mesh; and the ethanol volume concentration of the ethanol aqueous solution is 30% to 40%.
4. The compound preparation of cephalosporin antibiotics according to claim 1, characterized in that: In the preparation method of the leaf elephant flower extract, the ultrasonic mixing time is 30 minutes to 50 minutes.
5. The compound preparation of cephalosporin antibiotics according to claim 1, characterized in that: In the preparation method of Atractylodes lancea extract, the enzyme activity of the hemicellulase is 15000U / g to 25000U / g; the temperature of the heating sterilization and enzyme inactivation is above 90°C, and the time of the heating sterilization and enzyme inactivation is 15min to 20min; the mesh number of the sieve is 200 mesh to 250 mesh; and the ethanol volume concentration of the ethanol aqueous solution is 30% to 40%.
6. The method for preparing a compound preparation of cephalosporin antibiotics according to claim 1, characterized in that: The steps include: S1: by mass fraction, 80 to 100 parts of purified water, 1 to 3 parts of cephalosporin antibiotics, 0.3 to 1 part of pomegranate peel extract, 0.1 to 0.3 parts of 3-epi-betulinic acid, 0.2 to 0.8 parts of iris extract, 0.1 to 0.5 parts of atractylodes extract and 1 to 2.5 parts of glucose are prepared; S2: Heat the purified water to 35°C to 40°C, add glucose, pomegranate peel extract, 3-epibetolic acid, physalis extract and atractylodes extract and mix them evenly, then add cephalosporin antibiotics, mix evenly, and finally spray dry to obtain a compound preparation.
7. The use of a compound preparation of cephalosporin antibiotics according to claim 1, characterized in that: The compound preparation is combined with pharmaceutically acceptable excipients to form injections, oral medicines, sprays or skin compresses.
